Opinion
RealClearPolicy on MSNOpinion

Stop 340B Fraud or Let the Private Sector Lead

The U.S. Department of Health and Human Services has made eliminating fraud and waste a priority, with a focus on overpayments and price transparency for hospital and physician services. The rapidly ...
The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs ...
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient ...
It's time for Congress to bring stronger accountability to 340B and ensure that the program actually serves its intended ...
Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.
CMS plans to cut what Medicare pays hospitals for drugs bought through the 340B program and push site-neutral payment into a new category of outpatient services, two proposals that together would pull ...
Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...
I've lived since childhood with a rare primary immune deficiency that forces me to rely on weekly infusions to give my body the ability to fight off viruses and infections. I know firsthand how ...
The 8th Circuit court rejects Novartis bid to block Missouri's unlimited 340B contract pharmacy law, upholding state protections for contract pharmacies.
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...